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Abstract
Federal research regulations require participants to be informed about whether medical care or
compensation for injury is available in more than minimal risk studies and prohibit language in
informed consent documents that waives, or appears to waive, legal rights. The objectives of this
study were to compare data collected in 2000 and 2012 to identify significant changes in types of
institutional compensation policies at U.S. research institutions, and assess the relationship
between institutional characteristics and different types of policies. We found that research-related
injury compensation policies did not change substantially during the time period. A significant
percentage of policies contain language that can be reasonably interpreted as waiving, or
appearing to waive, legal rights. Level of funding, public vs. private status, and institutional
involvement in clinical research were associated with different types of policies. The lack of
substantial change in compensation policies supports arguments for a national policy.
Introduction
Human volunteers are sometimes injured as a result of their participation in research.
Though most injuries are minor, some injuries result in hospitalization, long-term disability,
or, in rare cases, death.[1] Participants may be required to pay for their medical care if they
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lack health insurance or if the insurance company, institution, or sponsor will not cover the
costs of care. Participants may also suffer economic and non-economic harms as a result of
their injuries, such as lost wages, pain and suffering, or missed opportunities for
employment.[2] Many U.S. research institutions and sponsors have adopted policies for
compensating injured research participants.[3,4] These policies can help remedy harms to
individuals and minimize litigation, but can also vary considerably.[3-5] Individuals with the
same research-related injuries in a multicenter study may ultimately receive different
remedies if they participate at different institutions. Although federal research regulations do
not mandate compensation for research-related injuries, they require that participants be
informed of the availability of medical care or compensation for injury (if any) for more
than minimal risk research.[6,7] Regulations also prohibit informed consent from including
any exculpatory language in which the participant (or his or her representative) waives or
appears to waive legal rights, or releases or appears to release the investigator, institution, or
sponsor from liability for negligence.[8,9]
To inform the public debate about this issue, it is important to have up-to-date information
concerning policies adopted by U.S. research institutions. Efthimios Parasidis (EP), a co-
author, published a 2000 study on compensation policies from 127 institutions.[5] More than
a third of the institutions surveyed offered no compensation for research-related injuries, and
42% offered compensation only at the discretion of the institution or sponsor.[5] However,
these data are more than ten years old, and the research environment has changed since then
as a result of increased legal liability risks related to oversight by federal agencies or
lawsuits from injured participants. At the same time, the risks inherent to the research have
increased as, for instance, companies are conducting innovative research related to gene
therapy, nanomedicine, and the development of biologics and new molecular entities. In
2005, the Lewin Group prepared a report for the Department of Health and Human Services
on care and compensation for injuries in clinical research.[10] The report identified 129
policies from 102 research institutions and found that the vast majority offered no
compensation for injuries. Although this report offers some useful information, it lacked
scientific rigor. For example, the sampling method and coding procedures were not well-
defined, no statistical methods were used, and the report was not published in the open
literature.[10]
The aim of our study was to conduct a rigorous description and analysis of research-related
injury compensation policies at U.S. research institutions by (1) comparing data from 2000
and 2012 to identify any significant changes in types of compensation policies, and (2)
determining whether institutional characteristics are associated with different types of
policies. Though our analysis focused on compensation for medical care, we also tried to
determine whether policies address compensation for more than medical care.
Methods
We worked with two datasets, one from EP's study and one collected for the current (2012)
study. EP provided us with documents from his study, which he performed with help from
Jon Merz. EP emailed members of MCWIRB (a discussion forum for individuals involved
in oversight of human subjects research now known as IRB Forum) a survey on March 2,
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2000, with two reminder emails. Eighty-nine out of 349 email recipients responded via
email or fax. To obtain additional data, the websites of the top 100 National Institutes of
Health (NIH)-funded institutions for fiscal year 1999 were examined. Sixty of these
institutions had information available on their webpages. After eliminating overlap between
emails and websites, EP's study included data from 127 institutions.
For our current study, we attempted to access policies from the top 200 funded U.S. research
institutions according to the most recent data available through the Center for Measuring
University Performance (CMUP).[11] We used the CMUP list because the MCWIRB email
list has changed considerably in 12 years, and the top 200 institutions on the CMUP list
include most of the top 100 NIH-funded institutions. We eliminated one institution,
University of California (UC) Central Administration, from the list because it does not
conduct research with human subjects, although specific schools within the UC system—
which were included—do.
We first attempted to access policies through publicly available websites. We defined a
compensation policy as language contained in institutional documents, such as informed
consent templates or standard operating procedures, which provide official guidance
concerning compensation for research-related injuries. When language in the consent
template conflicted with other sources of policy, we gave preference to the template; if a
participant sued for damages, the consent document could be crucial in determining liability.
[3] If we were unable to obtain policies on publicly available websites, we sent an email to
institutional representatives, such as Institutional Review Board (IRB) chairs or IRB
managers, asking them for a copy of institutional policies. We sent two reminder emails if
we received no response.
We coded compensation language based on a classification scheme developed for this study.
We recoded data from EP's earlier study using our new coding scheme. We developed the
coding scheme after reviewing the EP's study and examining about half the data from our
current study. We also consulted Office of Human Research Protections (OHRP) guidance
on exculpatory language.[12] Compensation was defined as, at a minimum, payment for
immediate medical care. Many institutions offer to provide immediate medical care, but this
is not the same as paying for it. For our purposes, we were interested in determining whether
institutions would pay for medical care, since participants may face tremendous burdens if
required to pay for medical care themselves.
We developed four models of compensation offers (No Compensation, Discretional
Compensation, Conditional Compensation, and Unconditional Compensation) and three
models of exculpatory language (Not Exculpatory, Potentially Exculpatory, and
Exculpatory) that correspond to conceptually distinct categories (see Box 1 and Box 2 for
definitions and examples). We also collected other data pertaining to policies, such as
whether policies offer different options for compensation language and whether there was an
offer to provide compensation beyond payment for immediate medical care.
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To ensure consistency, policies were coded independently by two people (JE and KC), who
received training in our coding procedure. Inter-rater agreement was assessed using kappa
statistics, and differences in coding were reconciled by a conference with the study team.
In addition to gathering data on compensation policies, we obtained data on five institutional
characteristics: NIH funding amount and rank, public vs. private status, geographical region,
and involvement in clinical research for responding and non-responding institutions. An
institution was classified as involved in clinical research if it was a medical school or was
associated with one, was a health care institution (such as a hospital), or was a contract
research organization that conducts or manages clinical trials. For example, Johns Hopkins
University would be classified as involved in clinical research because it has a medical
school. Institutions not involved in clinical research included universities or colleges that are
not associated with a medical school. For example, Massachusetts Institute of Technology
would be classified as not involved in clinical research. Institutions not involved in clinical
research might still have a compensation-for-injury policy because they might be conducting
non-clinical research that entails more than minimal risks, such as studies of human
physiology that involve muscle biopsies or cardiac stress tests.
To establish generalizability of the findings, we compared responders to non-responders
regarding institutional characteristics. We used Mann-Whitney tests for NIH funding and
rank, which were not normally distributed. We compared the other institutional
characteristics, which were categorical, using chi-square tests.
Among the respondents, further analyses compared 2000 and 2012 responses. Because some
institutions responded in 2000 and 2012 while others responded only once, we conducted
these analyses in two phases. Phase 1 compared 2000 responders to 2012 responders without
regard to whether institutions responded both times using Mann-Whitney tests for NIH
funding and rank, and chi-square tests for all other measures. Phase 2 compared only those
that responded both in 2000 and 2012. Because these measurements were likely correlated,
we used statistical methods for paired data. In particular, we used Wilcoxon signed ranks
tests to compare NIH funding and rank between the two time points. For categorical
measures, we determined the percentage of institutions that changed categories from 2000 to
2012 and tested these percentages for significance using binomial tests for proportions.
For the 2012 institutions, we investigated associations between institutional characteristics
and types of compensation policies using chi-square statistics or Fisher's exact test. Fisher's
exact test was used if one or more expected frequencies were less than five. For these
analyses, NIH funding, NIH funding rank, total funding and national rank were categorized
into quartiles; institutions having no NIH funding or NIH funding rank were placed into a
fifth separate category (Unfunded or Unranked, respectively).
All p-values were two-sided and any less than 0.05 were considered statistically significant.
SAS 9.2 (2008, SAS Institute, Cary NC) statistical software was used for data analysis.
Our current study was reviewed by the NIH's Office of Human Subjects Research
Protections, which determined that the federal research regulations do not apply to this
study, since we were not collecting private information about individuals. EP's study was
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approved by the University of Pennsylvania Committee on Studies Involving Human
Beings.
Results
Table 1 summarizes institutional characteristics for 2000 and 2012 data. The response rate
for 2000 was 127/372 (34.1%) and 2012 was 169/199 (84.9%). The main reason for the
different responses rates is that most of the 2012 data came from publicly available websites,
whereas most of the 2000 data came from email responses. The two raters had perfect
agreement in coding the type of compensation offered; there was disagreement concerning
coding of exculpatory language (kappa statistic p-value < 0.001). The raters disagreed on 36
of the 177 institutions (20.3%). Consensus ratings from members of the research team were
used in the statistical analyses.
Compensation Offered
A comparison of 2000 and 2012 data using Fisher's exact test yielded no statistically
significant differences in type of compensation offered (see Figure 1). The percentage of
institutions offering no compensation was 56.1% in 2000 and 51.2% in 2012; discretionary
compensation was 11.2% in 2000 and 8.1% in 2012; conditional compensation was 31.8%
in 2000 and 36.9% in 2012; and compensation without conditions was 0.9% in 2000 and
3.8% in 2012. When the analysis focused on the 57 institutions that responded both in 2000
and 2012, the only significant change is that 9.1% changed from no compensation in 2000 to
discretionary compensation in 2012 (p < 0.001). No institutions in 2000 and only two
institutions in 2012 (1.2%) offered compensation beyond payment for immediate medical
care.
Exculpatory Language
A comparison of 2000 and 2012 data using Fisher's exact test yielded no statistically
significant differences in exculpatory language (see Figure 2). The percentage of institutions
with no exculpatory language was 66.4% in 2000 and 78.4% in 2012; potentially
exculpatory language was 32.7% in 2000 and 21.2% in 2012; and exculpatory language was
0.9% in 2000 and 0.6% in 2012. When the analysis focused on institutions that responded in
2000 and 2012, the only significant change is that 10.9% changed from no exculpatory
language in 2000 to potentially exculpatory language in 2012 (p < 0.001).
Associations with Institutional Characteristics
We focused on 2012 data to determine whether types of compensation policies are
associated with institutional characteristics. NIH funding was significantly associated with
the type of compensation offered. For example, among the top ranked institutions, only
12.2% offered no compensation, as compared to 46.3% for the second quartile, 63.2% for
the third quartile, 86.1% for fourth quartile, and 75% for unranked (p < 0.001). We found
similar differences related to funding when we looked at total NIH funding instead of NIH
ranking (see Table 2). Institutional control was significantly associated with the type of
compensation offered. For example, 33.3% of private institutions offered no compensation,
as compared to 57% of public institutions (p < 0.013). Involvement in clinical research also
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was significantly associated with the type of compensation offered. For example, 32% of
institutions involved in clinical research offered no compensation, as compared to 80.9% not
involved in clinical research (p < 0.001). (See Table 2.).
Discussion
Our most important finding is that there have been no substantial changes in research-related
injury compensation policies among U.S. institutions since 2000. More than half of U.S.
research institutions currently offer no compensation for research-related injuries and less
than 5% offer unconditional compensation. Other important findings are that more than 20%
of institutions include potentially exculpatory language in consent forms, and 10.9% of
institutions changed from no exculpatory language in 2000 to potentially exculpatory
language in 2012. Regardless of whether the forms ultimately would be deemed by a court
to violate federal regulations, the forms are ethically problematic because they may lead
research participants to mistakenly believe that they have no right to sue research institutions
or sponsors for damages.
The lack of substantial change in institutional policies during this period suggests that
significant changes are unlikely to occur without additional government pressure, such as
legislation or administrative rule-making. The persistence of the status quo concerning
research-related injury compensation policies adds urgency to arguments in favor of a
national system. Since other writers [3,4] have made the case for a national system, we will
not discuss that option here.
Another important finding is that institutional characteristics were associated with different
types of policies. Some possible explanations of these associations are that top NIH-funded
institutions and institutions involved in clinical research may be more likely to conduct
research that exposes subjects to significant risks and may therefore be more likely to
develop policies to address research-related injuries. Private institutions may have more of
an incentive to develop compensation for injury policies than public ones because they face
greater legal risks, given existing legal barriers to suing public institutions. However, these
are speculative hypotheses, and more research is needed on the factors that influence policy
development.
It is worth noting that institutional practices for compensating research subjects for injuries
may diverge from institutional policies because some institutions may ultimately offer
compensation even if their policy does not promise it.[5] Institutions may provide
compensation on an ad hoc basis to avoid lawsuits or adverse publicity, or out of
compassion for injured participants. To better understand these issues, it may be useful to
conduct future studies on institutional practices and participants’ experiences with
compensation.
Our study has some potential limitations. First, the response rate for the EP study was
somewhat low, which could have led to a response bias. We compared responders and non-
responders for the 2000 data and found that responders received more NIH funding and
were ranked better. In addition, a higher percentage of responding institutions were involved
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in clinical research. However, institutional control, and geographic region were similar
between responders and non-responders. These differences may somewhat limit
generalizability of the 2000 findings. The response rate for the 2012 study was high, and a
comparison of responders and non-responders found no significant differences, which bodes
well for the generalizability of these findings.
Sample size is another potential limitation of our study. With a larger sample size, we may
have been able to detect statistically significant relationships not found in this sample.
Nevertheless, we believe that the sample was large enough to draw some useful conclusions
about compensation policies at U.S. institutions.
Conclusion
Research-related injury compensation policies at U.S. research institutions have changed
very little since 2000. The lack of substantial change in the last dozen years suggests that
changes are not likely to occur in the future without additional government pressure.
Policymakers should consider taking steps toward developing a national policy for
compensating injured research subjects, and institutions should take immediate steps to
ensure that their informed consent documents do not include language that waives, or
appears to waive, legal rights.
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This figure shows the percentages of institutions in the 2000 and 2012 samples having each
of the four types of compensation policies. Error bars represent 95% confidence intervals for
the percentages. The distribution of institutions among the four policy types in 2012 was not
significantly different from that in 2000 (Fisher's exact p-value = 0.38).
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This figure shows the percentages of institutions in the 2000 and 2012 samples having each
of the three categories of exculpatory language. Error bars represent 95% confidence
intervals for the percentages. The distribution of institutions among the three categories in
2012 was not significantly different from that in 2000 (Fisher's exact p-value = 0.063).
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